Nuveen’s Satsuma Pharmaceuticals STSA Stock Holding History
Bought
Maintained
Sold
Other funds holding STSA
GTC
Nuveen's STSA Position: Q2 2021 in Review
Nuveen sold out of Satsuma Pharmaceuticals (STSA) in Q2 2021, closing a stake of 35,379 shares — an estimated $826K sold.
Nuveen first reported a position in STSA in Q1 2020 and held it in 5 quarters. The position peaked at $1.3M in Q3 2020. 60 funds tracked by Wall St. Rank hold STSA as of Q2 2021.
- Nuveen reported no remaining Satsuma Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
- Nuveen sold 35,379 Satsuma Pharmaceuticals shares in Q2 2021, an estimated $826K.
- Nuveen first reported a position in Satsuma Pharmaceuticals in Q1 2020 and held it in 5 quarters.
- Nuveen's Satsuma Pharmaceuticals position peaked at $1.3M in Q3 2020.
- 60 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals as of Q2 2021.
Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.